Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3378-3387.e11. doi: 10.1016/j.jaip.2020.07.057. Epub 2020 Aug 20.
The coronavirus disease 2019 (COVID-19) pandemic caused dramatic changes in daily routines and health care utilization and delivery patterns in the United States. Understanding the influence of these changes and associated public health interventions on asthma care is important to determine effects on patient outcomes and identify measures that will ensure optimal future health care delivery.
We sought to identify changes in pediatric asthma-related health care utilization, respiratory viral testing, and air pollution during the COVID-19 pandemic.
For the time period January 17 to May 17, 2015 to 2020, asthma-related encounters and weekly summaries of respiratory viral testing data were extracted from Children's Hospital of Philadelphia electronic health records, and pollution data for 4 criteria air pollutants were extracted from AirNow. Changes in encounter characteristics, viral testing patterns, and air pollution before and after Mar 17, 2020, the date public health interventions to limit viral transmission were enacted in Philadelphia, were assessed and compared with data from 2015 to 2019 as a historical reference.
After March 17, 2020, in-person asthma encounters decreased by 87% (outpatient) and 84% (emergency + inpatient). Video telemedicine, which was not previously available, became the most highly used asthma encounter modality (61% of all visits), and telephone encounters increased by 19%. Concurrently, asthma-related systemic steroid prescriptions and frequency of rhinovirus test positivity decreased, although air pollution levels did not substantially change, compared with historical trends.
The COVID-19 pandemic in Philadelphia was accompanied by changes in pediatric asthma health care delivery patterns, including reduced admissions and systemic steroid prescriptions. Reduced rhinovirus infections may have contributed to these patterns.
2019 年冠状病毒病(COVID-19)大流行导致美国日常生活和医疗保健利用及提供模式发生了巨大变化。了解这些变化及其相关公共卫生干预措施对哮喘护理的影响,对于确定对患者结局的影响以及确定确保未来最佳医疗保健提供的措施非常重要。
我们旨在确定 COVID-19 大流行期间儿科哮喘相关医疗保健利用、呼吸道病毒检测和空气污染的变化。
在 2015 年 1 月 17 日至 2020 年 5 月 17 日期间,从费城儿童医院的电子健康记录中提取了与哮喘相关的就诊信息,以及每周呼吸道病毒检测数据摘要,从 AirNow 提取了 4 项空气质量标准污染物的数据。评估并比较了 2020 年 3 月 17 日(即费城开始实施公共卫生干预措施以限制病毒传播的日期)前后就诊特征、病毒检测模式和空气污染的变化,并与 2015 年至 2019 年的数据进行了比较,作为历史参考。
2020 年 3 月 17 日之后,门诊哮喘就诊减少了 87%(门诊)和 84%(急诊+住院)。以前不可用的视频远程医疗成为最常用的哮喘就诊方式(所有就诊的 61%),而电话就诊增加了 19%。与此同时,与历史趋势相比,哮喘相关全身类固醇处方和鼻病毒检测阳性率的频率均有所下降,尽管空气污染水平没有实质性变化。
费城的 COVID-19 大流行伴随着儿科哮喘医疗保健提供模式的变化,包括住院和全身类固醇处方减少。呼吸道病毒感染减少可能导致了这些模式的变化。